Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic disease of the joints that can cause a disabling degree of pain and significantly interfere with an individual’s day-to-day living.

What is Rheumatoid Arthritis?

Rheumatoid arthritis or RA is an inflammatory condition that affects joints primarily leading to pain and stiffness and difficulty in movements. Commonly affected joints are those of the hands, feet and wrists. RA however can also affect other parts of the body.

What Causes Rheumatoid Arthritis?

Rheumatoid Arthritis Symptoms

Rheumatoid Arthritis Diagnosis

Are There Any Natural Remedies for Rheumatoid Arthritis?

Rheumatoid Factor Test

Knee Rheumatoid Arthritis

Total Knee Replacement and Rheumatoid Arthritis

Hip Rheumatoid Arthritis

Rheumatoid Arthritis and Feet

Rheumatoid Arthritis and Pregnancy

Rheumatoid Arthritis, Family Planning & Pregnancy

See more featured articles »

Rheumatoid Arthritis and Gum Disease

Rheumatoid Arthritis and Depression

Rheumatoid Arthritis and Gout

Juvenile Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis Symptoms

Juvenile Rheumatoid Arthritis Types

Juvenile Rheumatoid Arthritis Diagnosis

Juvenile Rheumatoid Arthritis Treatment

Rheumatoid Arthritis Nodules

Rheumatoid Arthritis and Winter Weather

Rheumatoid Arthritis Treatment

Disease-Modifying AntiRheumatic Drugs (DMARDs)

Rheumatoid Arthritis Management

Radiotherapy and Rheumatoid Arthritis

Rheumatoid Arthritis and Acupuncture

Yoga and Tai chi in Rheumatoid Arthritis

Rheumatoid Arthritis and Exercise

Rheumatoid Arthritis Diet and Nutrition

Self-Help and Living with Rheumatoid Arthritis

Rheumatoid Arthritis Research

Rheumatoid Arthritis Support

Rheumatoid Arthritis Prognosis

Rheumatoid Arthritis Complications

Rheumatoid Arthritis Epidemiology

Rheumatoid Arthritis Skin Problems

Rheumatoid Arthritis History

Causes of Hand Pain

Rheumatoid Arthritis and Vitamin D

Psoriatic Arthritis vs Rheumatoid Arthritis

Can Antibiotics Increase the Risk of Arthritis?

Latest Rheumatoid Arthritis News and Research

AGA releases updated guidelines on hepatitis B reactivation in patients on immunosuppressive drugs

The American Gastroenterological Association (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive drugs.

23 Jan 2025

Granzyme K+ CD8+ T-cells identified as key drivers of recurrent airway inflammation

Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent respiratory diseases.

17 Jan 2025

Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in PTPN2.

17 Jan 2025

Wearable devices can identify and predict flare-ups in inflammatory bowel disease

Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a first-of-its-kind study.

16 Jan 2025

Dexter software platform reveals connection between early life trauma and immune disorders

University of Birmingham venture Dexter has demonstrated the power of its Dexter software platform in a study showing that people whose childhoods featured abuse, neglect or domestic abuse carry a significantly increased risk of developing rheumatoid arthritis or psoriasis in later life.

15 Jan 2025

Mayo Clinic partners with Microsoft Research and Cerebras to revolutionize AI in healthcare

Mayo Clinic today unveiled separate groundbreaking collaborations with Microsoft Research and with Cerebras Systems in the field of generative artificial intelligence (AI), designed to personalize patient care, significantly accelerate diagnostic time and improve accuracy.

15 Jan 2025

A new strategy for enhancing the production of protein-based drugs

An international team of researchers led by the University of California San Diego has developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, autoimmune diseases and much more.

15 Jan 2025

Proteomic mapping identifies biomarkers driving healthy aging and preventing chronic diseases

Scientists mapped the serum proteome longitudinally to uncover biomarkers linked to healthy aging and cardiometabolic diseases, revealing potential therapeutic targets.

14 Jan 2025

Gut microbiome dynamics reveal key factors influencing Enterobacteriaceae colonization

Analysis of gut microbiomes reveals co-colonization patterns and potential therapeutic targets against Enterobacteriaceae, addressing global health challenges.

14 Jan 2025

AI-based method predicts progression of autoimmune diseases

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that's characterized by mild symptoms or certain antibodies in the blood.

7 Jan 2025

University of Birmingham receives £3.5 million to study arthritis treatment responses

In recent years treatment with powerful biologic and targeted synthetic therapies has changed the landscape for arthritis, but currently finding the right treatment for each person is a matter of trial and error.

6 Jan 2025

Dextromethorphan found to have potential in treating lung fibrosis

A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions.

22 Dec 2024

Cough syrup ingredient may help combat lung fibrosis

A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions.

18 Dec 2024

New insights into Sjögren's disease pathogenesis and treatment

Researchers at NYU College of Dentistry and NYU Grossman School of Medicine are closer to understanding what drives the autoimmune disorder Sjögren's disease, thanks to new discoveries about the role of calcium signaling, regulatory T cells, and interferon.

18 Dec 2024